By Amy Jimenez
After many years of battling Hodgkin’s lymphoma, I was finally able to achieve remission in 2017 and am grateful today to call myself a cancer warrior and survivor. I was sick and misdiagnosed for many years until January of 2015 — none of my first rounds of treatments worked, and I eventually had to have an Autologous Stem Cell Transplant, which luckily saved my life.
I’ve worked in the acting and modeling industry for many years and now like to spend a lot of my time advocating for other cancer patients and their families. Access to treatment makes the difference between life and death for many cancer patients, and it’s imperative that any reforms to our healthcare system do not impede patients’ ability to get the medicines they need. Equally, innovative treatments saved my life, and I worry that giving the government too much control over the American innovation ecosystem will hurt the potential for new discoveries.
When politicians decide what our medicines are worth, they decide what we are worth, and I don’t think government should be making those decisions. We can’t fix one life-threatening problem by creating another.
Sign up to stay informed and learn how to protect innovation when it matters most.
©2024 Pharmaceutical Research and Manufacturers of America, 670 Maine Avenue, SW, Suite 1000, Washington, DC 20024
Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how we and third parties use pixel tags, and how that use affects you, click here.